Epidemiology, etiology and prevention of bladder cancer

被引:0
|
作者
Rozanec, Jose J. [1 ,2 ]
Secin, Fernando P. [3 ]
机构
[1] Hosp Britanico Buenos Aires, Buenos Aires, DF, Argentina
[2] Hosp Univ Austral, Buenos Aires, DF, Argentina
[3] UBA, Urol, Buenos Aires, DF, Argentina
来源
ARCHIVOS ESPANOLES DE UROLOGIA | 2020年 / 73卷 / 10期
关键词
Bladder cancer; Epidemiology; Risk factors; PERMANENT HAIR-DYES; CIGARETTE-SMOKING; DRINKING-WATER; RISK; EXPOSURE; ASSOCIATION; MORTALITY; HEALTH; LUNG; CYCLOPHOSPHAMIDE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bladder cancer is the seventh most frequent cancer on male population and eleventh within the whole inhabitants. Differences in incidence and mortality between countries and regions exist. Those differences depend on variables including epidemiological data, social and cultural features and economics amongst the several populations that are exposed to different risk factors and treatment approaches. Smoking is the strongest risk factor for bladder cancer, representing approximately 50% of the cases. Its alternative, the electronic cigarette does not seem to provide a decrease in risk of bladder cancer. Employment exposure to aromatic amines, aromatic polycyclic hydrocarbons and chlorate hydrocarbons, are still important risk factors. Water consumption with high levels of arsenic has also shown an increased risk of bladder cancer. Fast acetylators or genetic predisposition would be tentative risk factors. Some medical treatments with chemotherapy o radiation therapy increase bladder cancer risk. Identifying all these factors allows for progress in the field of prevention and early detection. The main objective is to decrease incidence and mortality related to bladder cancer.
引用
收藏
页码:872 / 878
页数:7
相关论文
共 50 条
  • [31] Etiology of bladder cancer - Facts and speculation
    Gehrke, S
    Staehler, G
    Kalble, T
    AKTUELLE UROLOGIE, 1996, 27 (06) : 391 - 399
  • [32] Colorectal Cancer: Epidemiology, Risk Factors, and Prevention
    Roshandel, Gholamreza
    Ghasemi-Kebria, Fatemeh
    Malekzadeh, Reza
    CANCERS, 2024, 16 (08)
  • [33] Emerging drivers of female bladder cancer: a pathway to precision prevention and treatment
    Zhang, Jianbin
    Jia, Haixia
    Han, Hui
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [34] A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia
    Cheluvappa, Rajkumar
    Smith, David P.
    Cerimagic, Sabina
    Patel, Manish I.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (07) : 1351 - 1360
  • [35] Epidemiology of epithelial ovarian cancer
    Webb, Penelope M.
    Jordan, Susan J.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 3 - 14
  • [36] Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients
    Neuzillet, Y.
    Geiss, R.
    Caillet, P.
    Paillaud, E.
    Mongiat-Artus, P.
    PROGRES EN UROLOGIE, 2019, 29 (14): : 840 - 848
  • [37] Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries
    Lakkis, Najla A.
    Adib, Salim M.
    Hamadeh, Ghassan N.
    El-Jarrah, Rana T.
    Osman, Mona H.
    CANCER CONTROL, 2018, 25 (01)
  • [38] Epidemiology and prevention of breast cancer
    Lagiou, A.
    ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (06): : 742 - 748
  • [39] Cancer prevention: Epidemiology and perspectives
    Levi, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (07) : 1046 - 1058
  • [40] Epidemiology and Prevention of Cutaneous Cancer
    O'Leary, Miriam A.
    Wang, Steven J.
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2021, 54 (02) : 247 - 257